(VTRS) Viatris - Performance -11.1% in 12m
VTRS performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-47.02%
#109 in Peer-Group
Rel. Strength
26.79%
#5620 in Stock-Universe
Total Return 12m
-11.05%
#118 in Peer-Group
Total Return 5y
-31.43%
#97 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | 4.27 |
| High / Low | USD |
|---|---|
| 52 Week High | 13.02 USD |
| 52 Week Low | 7.16 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 81.20 |
| Buy/Sell Signal +-5 | 0.12 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: VTRS (-11.1%) vs XLV (-5.3%)
5y Drawdown (Underwater) Chart
Top Performer in Pharmaceuticals
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| CORT NASDAQ Corcept Therapeutics |
-0.36% | 135% | 355% | 64.3 | 57.8 | 0.61 | 23.7% | -5.15% |
| NVS NYSE Novartis |
4.34% | 16.6% | 86.1% | 18.5 | 14 | 1.37 | 8.70% | 9.2% |
| LLY NYSE Eli Lilly |
-2.05% | -15.3% | 417% | 63.7 | 35.8 | 1.2 | 58.2% | 18.9% |
| NOVN SW Novartis |
1.68% | 4.53% | 55.5% | 18.4 | 13.9 | 1.36 | 8.70% | 9.2% |
| GSK NYSE GlaxoSmithKline |
-4.16% | 7.17% | 55.3% | 18.6 | 8.61 | 0.38 | -25.2% | 3.11% |
| AZN NASDAQ AstraZeneca |
-2.74% | -5.77% | 51.3% | 27.9 | 15.4 | 0.93 | 72.4% | 45.1% |
| SFZN SW Siegfried Holding |
-8.26% | -8.51% | 106% | 24.2 | 23.6 | 1.48 | -42.4% | -29.3% |
| UCB BR UCB |
4.73% | 19.8% | 64.1% | 31.1 | 22 | 1.04 | -22.4% | 39.5% |
Performance Comparison: VTRS vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for VTRS
| Total Return (including Dividends) | VTRS | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 2.32% | 0.95% | 4.08% |
| 3 Months | 29.24% | 1.54% | 19.65% |
| 12 Months | -11.05% | -5.25% | 12.88% |
| 5 Years | -31.43% | 45.67% | 113.48% |
| Trend Score (consistency of price movement) | VTRS | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 64% | 24.8% | 86.9% |
| 3 Months | 90.9% | -21.1% | 97.2% |
| 12 Months | -68.9% | -78.2% | 46% |
| 5 Years | -50.8% | 87.7% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th52.50 | 1.36% | -1.69% |
| 3 Month | %th62.00 | 27.27% | 8.01% |
| 12 Month | %th41.50 | -6.12% | -21.20% |
| 5 Years | %th51.00 | -52.93% | -67.88% |
FAQs
Does Viatris (VTRS) outperform the market?
No,
over the last 12 months VTRS made -11.05%, while its related Sector, the Health Care Sector SPDR (XLV) made -5.25%.
Over the last 3 months VTRS made 29.24%, while XLV made 1.54%.
Performance Comparison VTRS vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
VTRS vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -0.8% | -1.8% | -27% | -24% |
| US NASDAQ 100 | QQQ | -0.6% | -1.8% | -28.4% | -22% |
| German DAX 40 | DAX | -2.9% | 0.4% | -39.1% | -43% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -2.3% | -3% | -31.4% | -32% |
| Hongkong Hang Seng | HSI | 0.4% | -0.2% | -47.3% | -48% |
| India NIFTY 50 | INDA | 0.2% | 2.3% | -26.5% | -9% |
| Brasil Bovespa | EWZ | 4.7% | 0.5% | -43% | -14% |
VTRS vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 0.5% | 0.2% | -30.6% | -34% |
| Consumer Discretionary | XLY | -0.8% | -0.2% | -19.3% | -28% |
| Consumer Staples | XLP | 0.6% | 2.4% | -26.1% | -18% |
| Energy | XLE | -2.7% | -2.8% | -20.6% | -14% |
| Financial | XLF | 0.2% | -1.3% | -30.8% | -39% |
| Health Care | XLV | -1.4% | 1.4% | -17.1% | -6% |
| Industrial | XLI | -1.6% | -2.6% | -34.1% | -36% |
| Materials | XLB | -1.7% | -2% | -30.5% | -17% |
| Real Estate | XLRE | -0.3% | 2.9% | -26.4% | -22% |
| Technology | XLK | -0.8% | -4.6% | -31.3% | -20% |
| Utilities | XLU | -1.6% | -0.5% | -29.4% | -33% |
| Aerospace & Defense | XAR | -1.1% | -4.2% | -45.2% | -60% |
| Biotech | XBI | -4.4% | -1.3% | -17.4% | -4% |
| Homebuilder | XHB | -4.1% | -6% | -22.7% | -17% |
| Retail | XRT | -1.1% | -0.4% | -21.5% | -22% |
VTRS vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -1% | -2.97% | -12.1% | -5% |
| Natural Gas | UNG | 2.5% | 10.5% | 1.3% | -6% |
| Gold | GLD | -0.4% | 2.5% | -42% | -51% |
| Silver | SLV | -1.5% | 0.8% | -40.8% | -31% |
| Copper | CPER | -9.8% | -11% | -48% | -34% |
VTRS vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | -0.8% | 0.7% | -22.6% | -9% |
| iShares High Yield Corp. Bond | HYG | -0.5% | 1.1% | -23.6% | -21% |